microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor

被引:143
作者
Tao, Jun [1 ]
Wu, Deyao [2 ]
Xu, Bin [3 ]
Qian, Weichun [4 ]
Li, Pengchao [1 ]
Lu, Qiang [1 ]
Yin, Changjun [1 ]
Zhang, Wei [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China
[2] Yancheng City 1 Peoples Hosp, Nantong Med Coll, Affiliated Hosp 4, Dept Urol, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Affiliated Zhongda Hosp, Dept Urol, Nanjing 210009, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China
关键词
miR-133; epidermal growth factor receptor; prostate cancer; EXPRESSION; MIR-133A; CARCINOMA; ROLES;
D O I
10.3892/or.2012.1711
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been shown that regulation of EGFR expression in prostate cancer cells is mostly at the transcriptional level. microRNA-133 (miR-133) has long been recognized as a muscle-specific miRNA which may regulate myoblast differentiation and participate in many myogenic diseases. Recently, it has been reported that miR-133 is also involved in other tumors, such as bladder cancer, esophageal cancer and may regulate cell motility in these cancer cells. In the present study, we examined the expression and effects of miR-133 in two hormone-insensitive prostate cancer cell lines. The expression of miR-133a and miR-133b were analyzed by quantitative RT-PCR. After transfection of miR-133a and miR-133b, cell viability assay, luciferase assay, western blot analysis, cell migration and invasion assay were conducted in DU145 and PC3 cells. In this study, we showed that miR-133a and miR-133b are expressed at the detection limit in two hormone-insensitive prostate cancer cell lines, PC3 and DU145. Ectopic expression of miR-133 inhibited cell proliferation, migration and invasion in these cells. We also provide the first evidence that miR-133 may target EGFR. Our study provided the first glimpse of the functional role of miR-133 in two hormone-independent prostate cancer cell lines. These results may add to our knowledge on the molecular basis of prostate cancer progression.
引用
收藏
页码:1967 / 1975
页数:9
相关论文
共 21 条
[1]   Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer [J].
Ambs, Stefan ;
Prueitt, Robyn L. ;
Yi, Ming ;
Hudson, Robert S. ;
Howe, Tiffany M. ;
Petrocca, Fabio ;
Wallace, Tiffany A. ;
Liu, Chang-Gong ;
Volinia, Stefano ;
Calin, George A. ;
Yfantis, Harris G. ;
Stephens, Robert M. ;
Croce, Carlo M. .
CANCER RESEARCH, 2008, 68 (15) :6162-6170
[2]   MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction [J].
Bostjancic, Emanuela ;
Zidar, Nina ;
Stajer, Dusan ;
Glavac, Damjan .
CARDIOLOGY, 2010, 115 (03) :163-169
[3]   Mechanisms of Prostate Cancer Cell Survival After Inhibition of AR Expression [J].
Cohen, Michael B. ;
Rokhlin, Oskar W. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 106 (03) :363-371
[4]   Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells [J].
Gan, Y. ;
Shi, C. ;
Inge, L. ;
Hibner, M. ;
Balducci, J. ;
Huang, Y. .
ONCOGENE, 2010, 29 (35) :4947-4958
[5]   Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence [J].
Hernes, E ;
Fosså, SD ;
Berner, A ;
Otnes, B ;
Nesland, JM .
BRITISH JOURNAL OF CANCER, 2004, 90 (02) :449-454
[6]  
Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
[7]   miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma [J].
Kano, Masayuki ;
Seki, Naohiko ;
Kikkawa, Naoko ;
Fujimura, Lisa ;
Hoshino, Isamu ;
Akutsu, Yasunori ;
Chiyomaru, Takeshi ;
Enokida, Hideki ;
Nakagawa, Masayuki ;
Matsubara, Hisahiro .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) :2804-2814
[8]   Protein kinase Cδ signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells [J].
Kharait, S ;
Dhir, R ;
Lauffenburger, D ;
Wells, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 343 (03) :848-856
[9]  
Kim HG, 1999, HISTOL HISTOPATHOL, V14, P1175, DOI 10.14670/HH-14.1175
[10]   EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].
Mottet, Nicolas ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Schmid, Hans-Peter ;
Van der Kwast, Theo ;
Wiegel, Thomas ;
Zattoni, Filiberto ;
Heidenreich, Axel .
EUROPEAN UROLOGY, 2011, 59 (04) :572-583